SCHEMBL5479076

SCHEMBL5479076

C=CC(C)C(=O)C(C(=O)Nc1ccccc1)c1cccs1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.45
▸ POLB P06746 2/20 0.45
▸ TP53 P04637 1/20 0.45
▸ THRB P10828 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ MAPT P10636 4/20 0.44
▸ HTT P42858 1/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ ALDH1A1 P00352 4/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ ALOX5 P09917 1/20 0.38
▸ TGM2 P21980 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ HDAC1 Q13547 1/20 0.36
▸ MME P08473 1/20 0.36
▸ ACE P12821 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5462469 0.83 ALOX5 (0.44) LMNAPOLBTP53THRBNPSR1
SCHEMBL28102820 0.81 POLB (0.50) LMNAPOLBNPSR1MAPTHTT
SCHEMBL5464823 0.79 HTT (0.47) LMNAPOLBMAPTHTTALDH1A1
SCHEMBL10445357 0.77 LMNA (0.53) LMNAPOLBTP53THRBNPSR1
SCHEMBL11523349 0.76 ALDH1A1 (0.56) LMNAPOLBTP53NPSR1MAPT
SCHEMBL5471617 0.75 SMN1; SMN2 (0.48) LMNAPOLBMAPTALDH1A1KMT2A
SCHEMBL5457990 0.73 HTT (0.47) LMNAPOLBMAPTHTTKMT2A
SCHEMBL13462564 0.66 SMN1; SMN2 (0.55) LMNATP53MAPTHTTL3MBTL1
SCHEMBL29089510 0.65 POLB (0.58) LMNAPOLBNPSR1MAPTHTT
Acrylic Acid SCHEMBL27819647 0.65 ALOX5 (0.45) LMNAPOLBTP53THRBNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070149605-A1 Substituted pyrrole derivatives as hmg-coa reductase inhibitors RANBAXY LABORATORIES LIMITED (IN) 2007-06-28 — — US disclosed
EP-1643988-A1 SUBSTITUTED PYRROLE DERIVATIVES AS HMG-COA REDUCTASE INHIBITORS RANBAXY LABORATORIES, LTD. (IN) 2006-04-12 — — EP disclosed
WO-2004105752-A1 SUBSTITUTED PYRROLE DERIVATIVES AS HMG-COA REDUCTASE INHIBITORS RANBAXY LABORATORIES LIMITED (IN) 2004-12-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149605-A1 Substituted pyrrole derivatives as hmg-coa reductase inhibitors HMGCR, CYP46A1, GRHPR LMNA 1492/4885POLB 1998/4885TP53 3965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback